These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21655859)

  • 1. [Brazilian guidelines for bone and mineral disorders in CKD children].
    Lima EM; Gesteira Mde F; Bandeira Mde F;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():42-57. PubMed ID: 21655859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for bone and mineral disorders after kidney transplantation].
    Gueiros AP; Neves CL; Sampaio Ede A; Custódio MR;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():37-41. PubMed ID: 21655864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Foreword].
    de Carvalho AB; Jorgetti V
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():. PubMed ID: 21655854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for mineral and bone disorder in chronic kidney disease].
    Staszków M; Przedlacki J
    Wiad Lek; 2014; 67(3):422-5. PubMed ID: 25782204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mineral and bone disorders in renal transplantation].
    Bacchetta J; Lafage-Proust MH; Chapurlat R
    Nephrol Ther; 2013 Dec; 9(7):461-70. PubMed ID: 24176653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of lowering dialysate calcium on bone and mineral parameters related to adynamic bone disease.
    Spasovski G; Vanholder R
    Ther Apher Dial; 2007 Dec; 11(6):455-6; author reply 457. PubMed ID: 18028174
    [No Abstract]   [Full Text] [Related]  

  • 10. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
    Limardo M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone disease of prematurity.
    Sharp M
    Early Hum Dev; 2007 Oct; 83(10):653-8. PubMed ID: 17881164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lesions of the osteoarticular system in diabetes mellitus].
    Tkach SN; Shcherbak AV
    Klin Med (Mosk); 1986 May; 64(5):21-7. PubMed ID: 3088319
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adynamic bone disease].
    de Oliveira RB; Moysés RM; da Rocha LA; de Carvalho AB;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():19-20. PubMed ID: 21655858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Foreword. Brazilian clinical practice guidelines for mineral and bone disorders in chronic renal disease].
    de Carvalho AB
    J Bras Nefrol; 2011; 33(2):191. PubMed ID: 21789443
    [No Abstract]   [Full Text] [Related]  

  • 15. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
    National Kidney Foundation
    Am J Kidney Dis; 2003 Oct; 42(4 Suppl 3):S1-201. PubMed ID: 14520607
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral and bone disorder and vascular calcification in patients with chronic kidney disease.
    Peres LA; Pércio PP
    J Bras Nefrol; 2014; 36(2):201-7. PubMed ID: 25055361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kidney diseases and metabolic disorders-Basics and applications required for general physicians. Topics: VI. Chronic kidney disease and fragility fracture].
    Kazama JJ
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):948-52. PubMed ID: 26591344
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder.
    Costa AG; Bilezikian JP; Lewiecki EM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):324-9. PubMed ID: 26050118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines on bone mineral disorder in chronic kidney disease--addendum chapter 2].
    Carvalho AB; Gueiros AP; Gueiros JE; Neves CL; Karohl C; Sampaio E; Canziani ME; Custódio MR; Moysés RM; Barreto F; Jorgetti V
    J Bras Nefrol; 2012 Jun; 34(2):199-205. PubMed ID: 22850924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.